Type 1 diabetes is an autoimmune disease that can be triggered by viral infections.1 Recent studies have hypothesized that the COVID-19 pandemic might cause a global surge in diabetes diagnoses beyond what we typically see for patients with respiratory infections.2
Our data, however, showed similar rates of new type 1 diabetes diagnoses in COVID-19 admitted patients compared to admitted patients with an influenza diagnosis. As a baseline, we also examined rates of new diabetes diagnoses in patients admitted for trauma, which were slightly lower than rates in patients with COVID-19 or influenza diagnoses. Our results suggest that COVID-19 shares a similar risk profile for a new diagnosis of type 1 diabetes as other viral infections.